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Introduction
Biosurfactants are natural products of various micro-
organisms such as bacteria, yeasts and fungi. They are 
constituted of peptides, saccharides or lipids or their 
combinations (Ward 2010). Biosurfactants have an am-
phiphilic nature due to possessing both hydrophilic and 
hydrophobic moieties, thus making these compounds able 
to lower the surface tensions of water/air, oil/air, or the 
oil/water interfaces (Santos et al. 2016). Most biosurfac-
tants are either anionic or neutral, and few of them are 
cationic. The hydrophobic moieties of these molecules are 
made up of fatty acids, hydroxy fatty acids, or α-alkyl-
β-hydroxy fatty acids possessing greater chain lengths. 
The hydrophilic parts can be carbohydrates, amino acids, 
cyclic peptides, phosphates, carboxylic acids, or different 
alcohols (Mulligan 2005). According to a recent study 
there are several causes for microorganisms to produce 
biosurfactants, mainly the necessity of changing the sur-
face or interfacial properties of cells or the surrounding 
environment. These changes are mostly facilitating the 
formation and development of fruiting bodies and bio-
films, the gliding movement or the swarming of cells. The 
amount of lipopeptides produced by the bacteria can be 
influenced by altering the culture conditions, for example 
with the application of different carbon sources and metal 
ions (Bartal et al. 2018) or the pH control of the ferment 
broth (Czinkóczky and Németh 2020). These compounds 
play an important role in controlling cell development, 
therefore they have various therapeutic activities includ-
ing anti-microbial and anti-tumour effects (Mukherjee 
and Das 2010). Biosurfactants also possess important 
properties, such as low toxicity and specificity, more-
over they are relatively easy to prepare. These bioactive 
compounds have attracted considerable interest during 
the past decade. Due to their characteristics, there were 
several attempts for their industrial applications, for ex-
ample the bioremediation of organic chemicals, petroleum 
and petrochemicals, or their utilization as agrochemicals 
and fertilizers in agriculture. There are experiments for 
applications regarding food industry, cosmetics manufac-
turing, pharmaceuticals and detergents. Their attributes 
also propose the possibility for using biosurfactants as 
emulsifiers, demulsifiers, wetting agents, foaming agents 
and spreading agents (Volkering et al. 1997). 
Lipopeptides are a wide group of microbial biosurfac-
tants, consisting of a short linear or cyclic oligopeptide 
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linked to a fatty acid chain. They are produced by a 
high variety of microorganisms such as fungi, including 
Aspergillus, and several different bacteria, for example 
Pseudomonas, Streptomyces, and Bacillus. These compounds 
claimed the most attention due to the discovery of their 
antimicrobial, immunosuppressive, antitumor, and high 
surface activities (Cameotra and Makkar 2004; Gross and 
Loper 2009; Pirri et al. 2009; Raaijmakers et al. 2010). 
The proposed antimicrobial mechanism of lipopeptides 
is forming pores in the cellular membrane, resulting in 
an imbalance in ion flux leading to eventual cell death 
(Bender et al. 1999; Baltz 2009; Raaijmakers et al. 2010).
In 1968, Arima et al. isolated a substance in the form 
of needle-shaped white crystals from Bacillus subtilis and 
they named it “surfactin” due of its strong surface activ-
ity (Arima 1968). In addition to this property, surfactin 
was also proved to inhibit fibrin clot formation. Arima 
characterized surfactin as lipopeptide by its nature and 
its amino acids composition was also determined (Arima 
1968). During 1969 several studies have been made to 
elucidate the full structure of surfactin (Kakinuma et al. 
1969a, 1969b). The firstly described surfactin compound 
consists of a hydrophobic fatty acid “tail part” and a hy-
drophilic cyclic heptapeptide “head part” linked together 
by a lactone bridge (Bonmatin et al. 2003; Kakinuma et al. 
1969b). Subsequent studies in the next decades revealed 
that surfactins have more variants having different fatty 
acid chain lengths and various changes in their amino acid 
sequences ( Jenny et al. 1991; Lin et al. 1994; Yakimov et 
al. 1995; Kecskeméti et al. 2018). Surfactins have an acidic 
nature and can be dissolved in alkaline water and in polar 
organic solvents like methanol, ethanol, acetone, ethyl 
acetate, chloroform, methylene chloride and acetic acid, 
although it is insoluble in water, petroleum ester, hexane 
and other non-polar organic solvents. In its solid state, 
surfactin forms white, needle-shaped crystals, and it shows 
a powerful surface activity, exceeding that of sodium 
lauryl sulphate. Surfactin can lower the water's surface 
tension from 72 mN/m to 27 mN/m at very low concen-
trations (~0.005%). UV spectroscopic observations show 
that surfactin has no absorption in the range of 230 - 400 
nm (Arima et al. 1968).
Recently there is a growing interest in studying surfac-
tins, triggered by the increasing evidence for their poten-
tial as medical therapeutic agents, especially as antiviral, 
antimicrobial, anticancer, hemolytic, blood anticoagulant, 
and fibrinolytic agents (Al-Ajlani et al. 2007). Surfactin 
is produced mainly by the Gram-positive, endospore-
forming bacteria Bacillus subtilis (Peypoux et al. 1999), 
as well as B. pumilus, B. amyloliquefaciens, B. licheniformis, 
and B. mojavensis (Alvarez et al. 2011; Chen et al. 2015).
In the past decades there has been a growing scientific 
and industrial attention towards using naturally produced 
biosurfactants instead of their chemically synthesized 
counterparts. The main reason behind this is the ad-
vantages of these natural compounds such as their low 
toxicity, easier biodegradability and possible specific 
activity amongst extreme conditions. While increasing 
number of the different surfactin variants reported, there 
is a lack of information regarding their exact structure 
and the possible differences in their biological activities. 
Therefore, the aim of our work was the purification of 
the different surfactin variants by various separation 
techniques for their further structural elucidation and to 
serve possibilities for the detailed examinations of their 
biological activities.
Materials and Methods
Culture conditions and sample preparation
The examined Bacillus subtilis strain SZMC 6179J was 
previously isolated from tomato rhizosphere and its 
antagonistic properties were characterized and reported 
by Vágvölgyi et al. (2013).
For the surfactin production, a liquid ferment broth 
was applied according to the method described by Besson 
et al. (1987). It contained 10 g/L glucose, 5 g/L glutamic 
acid, 1 g/L KH2PO4, 1 g/L K2HPO4, 1 g/L KCl, 500 mg/L 
MgSO4 × 7 H2O, 5 mg/L FeSO4 × 7 H2O, and 160 µg/L 
CuSO4 × 5 H2O. Bacteria were inoculated into 4 x 1 L 
medium in four 2-L Erlenmeyer flasks, then incubated 
on a rotary shaker at 120 rpm for 5 days at 25 °C. After 
this, the cells were removed from the ferment broth by 
centrifugation (4 °C, 8000 rpm, 15 min) using aliquots 
in 50 mL Falcon tubes. Peptides were precipitated from 
the supernatant acidified to pH 2 by the addition of 
hydrochloric acid (VWR Chemicals, Hungary). After an 
overnight incubation at 4 °C, the acidified ferment broth 
was centrifuged (4 °C, 8000 rpm, 15 min), the supernatant 
was discarded, and the collected pellet was resolved in 50 
mL methanol. The remaining particulates were removed 
by centrifugation, and after the addition of 1 g silica gel 




The crude extract from the B. subtilis strain SZMC 6179J 
containing the produced surfactin compounds was pre-pu-
rified for separation by a CombiFlash EZ Prep Streamline 
Flash and Preparative HPLC Chromatograph (Teledyne 
ISCO, USA). The sample evaporated on silica gel (Molar 
Chemicals, Hungary) was loaded into a RediSep 25 g car-
tridge (Teledyne ISCO, USA), while the silica gel used for 
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the purification was loaded into a Biotage 50g cartridge 
(Teledyne ISCO, USA). The applied elution program was 
isocratic using two solvents: 70% toluene (eluent A, Molar 
Chemicals, Hungary) and 30% methanol (eluent B, Molar 
Chemicals, Hungary) of five column volumes (500 mL). 
The flow rate was 40 mL/min and 20 mL fractions were 
collected into 30 mL test tubes leading to 25 fractions 
altogether and the length of the run was 12.5 min.
Preparative and semi-preparative HPLC methods
After the flash chromatographic run, a preparative HPLC 
purification was carried out to further cleanse the sample 
from contaminants for facilitating the actual isolation 
of the different surfactin variants by a semi-preparative 
HPLC separation. Both of them were performed by the 
aforementioned CombiFlash EZ Prep instrument (Tele-
dyne ISCO, USA) in reverse phase and with the same 
solvents: eluent A was water and eluent B was a mixture 
of acetonitrile/methanol (1:1, V/V %, Molar Chemicals, 
Hungary), both solvents supplemented with 0.1% acetic 
acid (VWR International, Hungary).
The preparative step was achieved on a Phenomenex 
Gemini-NX (Phenomenex, USA) column (5µ, C18, 100 
× 21.20 mm) using the following gradient elution time 
program: 30% of eluent B for 2 min followed by a sheer 
increase to 75% in 2 min. Then a slower, linear increase 
to 95% follows ending at 30 min, where this rate was held 
for 15 min, then decreased to the initial 30% in 2 min and 
remained constant until the pressure stabilized ending 
the run of 60 min in total. The flow rate was 10 mL/min, 
the injection volume was 5 mL and 20 mL fractions were 
collected into 30 mL test tubes, having 30 fractions in total.
The semi-preparative isolation was executed on a 
BioBasic-18 (Thermo Scientific, USA) column (5µ, C18, 
250 × 10 mm) with an isocratic elution of 80% eluent B 
for 90 min. The flow rate was 5 mL/min, the injection 
volume was 1 mL and fractions collected every 5 mL into 
13 mL test tubes, resulting in 90 fractions.
Analytical HPLC-MS methods
The purity of the crude extracts and the fractions of the 
flash chromatographic and preparative HPLC separa-
tions, as well as the identification and relative quantitative 
examination of the semi-preparative HPLC fractions 
were carried out by HPLC-HESI-MS measurements. The 
applied instrument was a Nexera XR HPLC (Shimadzu 
Corporation, Japan) coupled with a TSQ Quantum Access 
triple quadrupole mass spectrometer (Thermo Scientific, 
USA). Both the quantitative and qualitative acquisitions 
implemented the eluents of the preparative and semi-
preparative HPLC isolations described above, and also the 
following reverse phase gradient elution time program was 
utilized in both cases: 5% eluent B for 2 min, increased to 
80% in the following 2 min, then gradually raised to 95% 
at 24 min. This rate was held for 9 min, then dropped to 
5% in 2 min, followed by a 5 min long equilibration stage, 
ending the run of 40 min in total. The flow rate was 0.2 
mL/min and the column heater temperature was 30 °C. 
The applied column was a Gemini-NX (3µ, C18, 150 × 2 
mm). The injection volume was 10 µL.
Both the purity checking, and the identifying measure-
ments were carried out with heated electrospray ioniza-
tion (HESI) ion source and in positive polarity. The spray 
voltage was +4000 V, the vaporizer temperature was 285 
°C, the capillary temperature was 350 °C, the sheath gas 
pressure was 10 psi and the auxiliary gas pressure was 
15 psi. The examinations of the purified fractions were 
achieved in full scan mode set between 900 – 1600 m/z 
values with the scan time of 1 sec/scan. The identifica-
tion of the different surfactin variants were performed in 
single reaction monitoring (SRM) mode with a collision 
energy of 60 V. The m/z values of sodiated surfactin mol-
ecules were set as parent ion masses (m/z 1016.7, 1030.7, 
1044.7, 1058.7, 1072.7, 1086.7, 1100.7, 1114.7) and for every 
parent ion, the first two internal fragment ions of every 
natural surfactin variant were set as a daughter ion (m/z 
580.7, 594.7, 608.7, 622.7, 679.7, 693.7, 707.7, 721.7, 735.7) 
(Kecskeméti et al. 2018). Simultaneously with the SRM 
analyses, selected ion monitoring (SIM) mode was also 
used for the relative quantitative measurement of the 
detected isoforms and homologues, examining the par-
ent ion m/z values listed above. With these two modes, 
80 different scan events ran parallel, each for a scan time 
of 0.1 sec/scan.
Results
Analysis of crude surfactin extract
After the extraction of the lipopeptides from the ferment 
broth, the initial purity of the crude extract was mea-
sured by HPLC-HESI-MS examination in full MS mode 
(Fig. 1A). By calculating the integrated area of all peaks 
of the total ion chromatogram (TIC) of the sample and 
the extracted ion chromatogram (EIC) of all m/z values 
belonging to surfactins, which eluted from 20 min to 28 
min, their ratio was observed in the crude extract to be 
21.35%. As it can be seen, many contaminants appeared 
mostly at the lower retention time region, therefore the 
inclusion of a pre-purification step was recommended 
before loading our sample on a preparative HPLC column 
in large amounts. For that purpose, flash chromatographic 
separation was applied.
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Flash chromatographic and preparative HPLC separa-
tion 
Every fraction of the flash chromatographic separation 
was collected and their surfactin content and purity were 
measured by HPLC-HESI-MS technique in full MS mode. 
Although it could be observed that the relative amount of 
contaminants decreased considerably, the peak around 
the ten minute mark still exceeds the intensity of surfac-
tins (Fig. 1B). Based on the calculation of the integrated 
peak areas of both the TICs and the EICs of all fractions 
the relative amount of surfactins and their purity were 
determined (Fig. 2). Based on these calculations, fractions 
4 – 7 were pooled, while the rest were discarded. The ratio 
of surfactins in this pooled sample was 30.44%. 
To further purify the sample from impurities, a pre-
parative HPLC isolation was performed on the sample 
containing the combined fractions 4 - 7. Following the 
preparative HPLC separation, the resulting 30 fractions 
were collected and their relative surfactin content and 
its purity were measured also by HPLC-HESI-MS ex-
aminations. Comparing the chromatograms (Fig. 1), it 
can be outright seen that most of the contaminants were 
separated from surfactins, all the peaks possessing lower 
retention times disappeared, only some minor impurities 
can be observed among the peaks of surfactins, suggesting 
that these compounds bear similar affinity to the station-
ary phase, therefore eluted along with the lipopeptides 
to be isolated (Fig. 1C). After the evaluation of all frac-
tions, the intensities and area ratios of surfactins were 
calculated (Fig. 3). For the most efficient isolation of the 
different surfactin variants, the combined fractions are 
recommended to be as pure as possible, while the sample 
should contain relatively high amount of surfactins. For 
these considerations, fractions 9 - 13 were merged and the 
rest of those that contain these lipopeptides were stored 
for subsequent purification. The final surfactin ratio of 
the pooled sample was 85.39%.
Semi-preparative HPLC separation
As a final step, a semi-preparative HPLC separation was 
carried out for the isolation of the different surfactin 
homologues and isoforms. The identification of the de-
tected surfactin variants and their relative amounts were 
measured in all the fractions by HPLC-HESI-MS tech-
nique, in SRM and full MS modes, respectively (Fig. 4).
By the examination of the MS2 spectra of all fractions 
of the semi-preparative HPLC separation, 9 molecules 
were identified altogether, with 4 different amino acid 
sequences ([Sur], [Val2], [Val7], [Val2,7]) and with 3 dif-
ferent fatty acid chain lengths (C13-C15). Out of the 9 
variants, only C13-[Val2], C15-[Val7] and C15-[Sur] were 
Figure 1. The total ion chromatogram of surfactins in the crude extract 
(A), in the 6th fraction of the flash chromatographic separation (B) and 
the 10th fraction of the preparative HPLC separation (C).
Figure 2. The intensities (A) and purities (B) of each fraction of the 
preparative flash chromatographic separation.
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detected with more than 99% ratio in a fraction. In the 
cases of C15-[Val7], C14-[Val2,7], C13-[Sur], C14-[Val2], 
C14-[Val7] and [C14-Sur], their most pure fractions had 
ratios of 98.55%, 43.66%, 95.34%, 53.81%, 98.69% and 
77.54%, respectively. The relative amounts of these mol-
ecules were also observed in comparison to the total 
integrated peak areas of every variant in every fraction 
(Fig. 5). Among the 9 molecules, C14-[Val7] and C14-[Sur] 
were found in the highest relative amounts, in 21.40% and 
20.81%. They were followed by C14-[Val2,7], C15-[Val7], 
C15-[Sur] and C13-[Val7], with the area ratios of 12.13%, 
11.10%, 11.05% and 10.93%, respectively. C13-[Sur] was 
observed in 7.12% of the total peak area, while C14-[Val2] 
had a ratio of 4.18% and C13-[Val2] had been found in 
the lowest relative amount, it only possesses 1,29% of 
the total surfactin amount detected in the fractions of 
the semi-preparative HPLC separation.
The efficiencies of the different separation steps
After each purification step the collected and merged 
fractions were evaporated and the weights of the dry mat-
ters were measured. The weights of surfactins and other 
impurities were calculated based on their respective peak 
area ratios of the HPLC-HESI-MS analyses, giving the 
efficiencies of the different separation techniques (Fig. 6).
In terms of peak area ratios, 21.35% of the total area 
belonged to surfactins in the crude extract. It was only 
Figure 3. The intensities (A) and purities (B) of each fraction of the 
preparative HPLC separation.
Figure 4. Fractogram of the identified surfactin variants (A) separated 
by semi-preparative HPLC technique and the ratios of surfactins in 
the fractions (B).
Figure 5. Ratios of the integrated peak areas of the different surfactin 
variants in fractions of the semi-preparative separation.
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increased to 30.44% after the flash chromatographic sepa-
ration and the preparative HPLC purification technique 
raised the ratio of surfactins up to 85.39% altogether.
Based on these data and the measured weights of 
the dry matters, 74.18% of contaminants were removed 
by flash chromatography, and 95.59% of the remaining 
impurities were cleansed during preparative HPLC, 
leaving only 1.20% of the total amount of contaminants 
in the sample. On the other hand, the preparative flash 
chromatographic isolation removed 58.36% of surfactins 
as well, only to be further decreased by 41.10% by the 
preparative HPLC separation step. Thus, the calculated 
amount of surfactins remaining in the sample was only 
24.53% that of the crude extract. This might be the ex-
planation to the rather peculiar observation that only 9 
different surfactin variants were detected in the fractions 
of the semi-preparative HPLC separation, although this 
strain is known to produce far more and in much higher 
variety of the different isoforms and homologues, which 
may have been lost during the purification process. Es-
pecially the loss of the molecules possessing longer fatty 
acid chains suggest that they were discarded among with 
the fractions collected later and having less area ratios 
than the ones being collected and merged.
In conclusion, the developed multi-step purification 
and separation of surfactins proved to be successful, more 
than 98% of the contaminants detected in the crude extract 
were removed and the C13-[Val2], C15-[Val7] and C15-
[Sur] variants were completely isolated from the rest of the 
molecules, while three others were detected in more than 
95% in some fractions. The efficiency of the separation 
however needs to be optimized, since around 75% of the 
calculated starting amount of surfactins were lost during 
the process, possibly including the homologues having 
more than 15 carbon atoms in their fatty acid chains. The 
flash chromatographic technique is especially in need of 
further development, subsequent repetitions of this step 
might be a suitable solution for decreasing the loss of 
surfactins and for increasing its purification potential.
Discussion
Surfactins have many potential applications, especially 
regarding therapeutic and environmental issues. The 
first example for the former was discovered by Arima 
et al. (1968); they observed that surfactin inhibits fibrin 
clot formation. Many other therapeutic activities were 
discovered later, e.g., antimycoplasmal, antibacterial and 
antiviral, anti-adhesive and anti-inflammatory effects 
(Vollenbroich et al. 1997; Kracht et al. 1999; Mulligan 2005; 
Heerklotz and Seelig 2006; Cho et al. 2006; Seydlová and 
Svobodová 2008). Furthermore, the use of surfactins as 
biosurfactans is an alternative to replace the chemically 
synthesized surfactant compounds. Biosurfactants are 
biodegradable and have lower toxicity (Kosaric 1992). 
The length of the fatty acid chain and the amino acid 
sequence varies, resulting in numerous isoforms of the 
surfactins in previous works (Bonmatin et al. 2003). 
Although most of these variants were reported in the 
1990s, our recent studies introduced novel surfactin 
molecules containing the following modifications: Val in 
the second amino acid position [Val2] (Bóka et al. 2016), 
aspartic acid 4-methyl ester at the fifth and Val in the 
seventh positions [AME5, Val7], leucine or isoleucine in 
the fourth and AME at the fifth positions [Lxx4, AME5] 
(Kecskeméti et al. 2018). Furthermore, it was also re-
ported that the culture conditions of the producer strain 
could significantly influence the relative amounts of the 
individual members of surfactins produced allowing 
the selective production of certain groups of surfactins 
(Bartal et al. 2018). 
However, the newly discovered surfactin variants were 
only characterized via spectrometric techniques and the 
confirmation of their exact structure will be important 
(for this the pure form of these compounds would be 
necessary in relatively large quantities). Furthermore, 
distinct surfactin variants could have different biological 
activities, as described by Aleti et al. (2016). They noted 
that two different surfactin variants with subtle struc-
tural differences had varying effects on bacterial biofilm 
formation on plant roots.
Therefore, in our work a multi-step purification and 
separation process was developed to isolate surfactins 
from the crude extract of the ferment broth of B. subtilis 
SZMC 6179J strain and to separate the different variants 
and homologues of this lipopeptide family. The method 
incorporates normal phase flash chromatography for 
Figure 6. Measured weights of the dry matters after each separation 
step and the calculated weights of surfactins and the contaminants 
based on the peak area ratios of the HPLC-HESI-MS measurements.
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pre-purifying the crude extract and two consecutive 
reverse phase high performance liquid chromatographic 
techniques; one with a preparative column to further 
cleanse the sample from contaminants, which was fol-
lowed by a semi-preparative RP-HPLC for the isolation of 
the various surfactin molecules. The measurement of the 
relative amounts of lipopeptides in the crude extract and 
in each fraction of every step was carried out by HPLC-
HESI-MS examinations, as well as the identification of 
the different surfactin variants detected in the fractions 
of the semi-preparative HPLC separation.
The measured weight of the crude extract was 492.25 
mg and the peak area ratio of surfactins in it was 21.35%. 
After the preparative flash chromatographic separation, 
fractions 4 - 7 were merged and kept for further purifica-
tion. The weight of the dry matter found in these fractions 
was 143.71 mg and the relative amount of surfactins was 
observed to be 30.44%. Fractions 9 - 13 of the preparative 
HPLC purification step were collected together, their 
dry matter weighting 30.18 mg altogether, while the 
integrated peak area of surfactins were 85.39% that of 
the total area of peaks detected in this sample, meaning 
that more than 98% of impurities detected in the crude 
extract were removed by these separation steps, however, 
about 75% of surfactins were also lost during the process.
Examination of the fractions of the semi-preparative 
HPLC isolation technique showed that altogether 9 dif-
ferent surfactin variants were isolated and identified, out 
of which 3 compounds were completely purified, and 
other 3 were detected in relative amounts of more than 
95% in some fractions.
These results suggest that the developed multi-step 
method is applicable for the purification of surfactin 
isoforms and homologues for subsequent structural 
characterization by spectroscopic techniques, however, 
further optimization is necessary to increase the efficiency 
of the whole process. 
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